Increased EpCAM levels are typical for epithelium-derived tumors, and EpCAM overexpression in tumor tissue has been associated with poor prognosis in breast, pancreatic, urothelial, and gallbladder carcinoma [14,15,16,17]. The gene discussed is EPCAM; the disease is neoplasm.